Free Trial

Portage Biotech (PRTG) SEC Filings & 10K Form

Portage Biotech logo
$5.01
-0.57 (-10.22%)
(As of 11/4/2024 ET)

Recent Portage Biotech SEC Filings

DateFilerForm TypeView
10/04/2024
3:30 PM
Portage Biotech (Filer)
Form 424B3
10/04/2024
3:15 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/03/2024
8:18 PM
Portage Biotech (Subject)
Shaw Allan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/27/2024
3:28 PM
Portage Biotech (Subject)
Shaw Allan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/23/2024
8:41 AM
MINTZ STEVEN (Reporting)
Portage Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2024
10:25 AM
Bailey Gregory (Reporting)
Portage Biotech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/27/2024
11:15 PM
Portage Biotech (Filer)
Form EFFECT
08/27/2024
7:30 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2024
5:05 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2024
5:11 AM
Portage Biotech (Filer)
Form 424B3
08/15/2024
7:31 AM
Portage Biotech (Filer)
Form 424B3
08/15/2024
7:00 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/14/2024
4:29 PM
Portage Biotech (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
08/13/2024
7:52 AM
Portage Biotech (Filer)
Form 424B3
08/13/2024
7:00 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2024
3:31 PM
Portage Biotech (Filer)
Form 424B3
04/12/2024
4:21 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/12/2024
4:22 PM
Portage Biotech (Filer)
Form 424B3
03/08/2024
4:30 PM
Portage Biotech (Filer)
Form 424B3
03/08/2024
4:04 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2024
8:11 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2024
8:36 PM
Portage Biotech (Filer)
Form 424B3
02/28/2024
4:19 PM
Portage Biotech (Filer)
Form 424B3
02/14/2024
2:50 PM
ARMISTICE CAPITAL, LLC (Filed by)
Portage Biotech (Subject)
Form SC 13G
01/18/2024
4:09 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/04/2024
7:10 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/01/2023
3:05 PM
Portage Biotech (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/28/2023
3:01 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/28/2023
3:02 PM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/28/2023
3:03 PM
Portage Biotech (Filer)
Form 424B3
11/14/2023
5:00 AM
Portage Biotech (Filer)
Form 424B3
11/13/2023
5:10 AM
Portage Biotech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2023
11:15 PM
Portage Biotech (Filer)
Form EFFECT
11/07/2023
3:50 PM
Portage Biotech (Filer)
Form 424B3
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PRTG) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners